The 118 undersigned organizations - representing people living with epilepsy; caregivers and loved ones; physicians, care providers, and epilepsy centers; epilepsy researchers; and others - are united ...

Quiver Bioscience Inc. is collaborating with the Dup15q Alliance to advance an antisense oligonucleotide (ASO) therapeutic program for chromosome 15q duplication (Dup15q) syndrome. BioWorld Science ...

--(BUSINESS WIRE)--Quiver Bioscience (“Quiver”), a discovery technology and therapeutics company advancing programs for the treatment of serious central nervous system (CNS) disorders, announces today ...

There are currently no disease-modifying treatments for Dup15q, which remains a substantial unmet medical need. Dup15q is a neurodevelopmental disorder characterized by moderate-to-severe ...